Global Short-Acting Nicotine Replacement Therapy Products Market 2026 by Company, Regions, Type and Application, Forecast to 2032

November 2026 | 135 pages | ID: G3AFA509850AEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Short-Acting Nicotine Replacement Therapy Products market size was valued at US$ 1862 million in 2025 and is forecast to a readjusted size of US$ 2676 million by 2032 with a CAGR of 5.5% during review period.

Short-acting nicotine replacement therapy (NRT) products are non-combustible smoking cessation aids designed to rapidly release and deliver nicotine—typically via the oral mucosa or nasal passages—to alleviate sudden cravings and nicotine withdrawal symptoms during the quitting process. Key examples include nicotine gum, lozenges, oral sprays, nasal sprays, and certain fast-release oral formulations. Sold primarily through pharmacies, hospitals, retail outlets, and online platforms, these products are widely used to help smokers quit and reduce tobacco dependence; their market continues to grow alongside the advancement of public health tobacco control policies, rising awareness regarding smoking cessation, and increasing consumer acceptance of over-the-counter smoking cessation aids.

The short-acting nicotine replacement therapy products market is primarily driven by continued implementation of tobacco-control policies, rising motivation among smokers to quit, growing demand for nicotine dependence treatment, and increasing consumer acceptance of convenient smoking cessation aids. Compared with long-acting products such as nicotine patches, short-acting formats including nicotine gum, lozenges, oral sprays, and nasal sprays can provide relatively rapid relief from sudden cravings and withdrawal symptoms, while offering flexible, on-demand dosing. These characteristics make them suitable both as standalone therapies and in combination with long-acting nicotine patches for more comprehensive craving management. At the same time, wider promotion of evidence-based smoking cessation interventions by healthcare providers and public health organizations, expansion of over-the-counter and online pharmacy channels, and growing awareness of the health risks associated with smoking and secondhand smoke are expanding the potential user base. Continued innovation in flavors, dosage forms, nicotine strengths, and portability is also improving treatment adherence and user convenience, further supporting growth of the global short-acting nicotine replacement therapy products market.

Report Scope

This report is a detailed and comprehensive analysis for global Short-Acting Nicotine Replacement Therapy Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

  • Global Short-Acting Nicotine Replacement Therapy Products market size and forecasts, in consumption value ($ Million), 2021-2032
  • Global Short-Acting Nicotine Replacement Therapy Products market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
  • Global Short-Acting Nicotine Replacement Therapy Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
  • Global Short-Acting Nicotine Replacement Therapy Products market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Short-Acting Nicotine Replacement Therapy Products
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Short-Acting Nicotine Replacement Therapy Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kenvue, Perrigo, Dr. Reddy's Laboratories, Haleon, Philip Morris International, Cipla, Rusan Pharma, Glenmark Pharmaceuticals, Piramal Pharma, Rubicon Consumer Healthcare, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Short-Acting Nicotine Replacement Therapy Products market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Market segment by Type

  • Nicotine Gum
  • Nicotine Lozenges
  • Nicotine Mouth Spray
  • Nicotine Nasal Spray
  • Others
Market segment by Dose

Low Dose

Medium Dose

High Dose

Market segment by Application

  • Online Sales
  • Offline Sales
Market segment by players, this report covers

Kenvue

Perrigo

Dr. Reddy's Laboratories

Haleon

Philip Morris International

Cipla

Rusan Pharma

Glenmark Pharmaceuticals

Piramal Pharma

Rubicon Consumer Healthcare

Alkalon

Sparsha Pharma

TFI India Labs

Nico Orgo Marketing

Lucy Goods

Blip

AdhexPharma

Jones

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Chapter Outline

Chapter 1, to describe Short-Acting Nicotine Replacement Therapy Products product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Short-Acting Nicotine Replacement Therapy Products, with revenue, gross margin, and global market share of Short-Acting Nicotine Replacement Therapy Products from 2021 to 2026.

Chapter 3, the Short-Acting Nicotine Replacement Therapy Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Short-Acting Nicotine Replacement Therapy Products market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Short-Acting Nicotine Replacement Therapy Products.

Chapter 13, to describe Short-Acting Nicotine Replacement Therapy Products research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Short-Acting Nicotine Replacement Therapy Products by Type
  1.3.1 Overview: Global Short-Acting Nicotine Replacement Therapy Products Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Type in 2025
  1.3.3 Nicotine Gum
  1.3.4 Nicotine Lozenges
  1.3.5 Nicotine Mouth Spray
  1.3.6 Nicotine Nasal Spray
  1.3.7 Others
1.4 Classification of Short-Acting Nicotine Replacement Therapy Products by Dose
  1.4.1 Overview: Global Short-Acting Nicotine Replacement Therapy Products Market Size by Dose: 2021 Versus 2025 Versus 2032
  1.4.2 Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Dose in 2025
  1.4.3 Low Dose
  1.4.4 Medium Dose
  1.4.5 High Dose
1.5 Global Short-Acting Nicotine Replacement Therapy Products Market by Application
  1.5.1 Overview: Global Short-Acting Nicotine Replacement Therapy Products Market Size by Application: 2021 Versus 2025 Versus 2032
  1.5.2 Online Sales
  1.5.3 Offline Sales
1.6 Global Short-Acting Nicotine Replacement Therapy Products Market Size & Forecast
1.7 Global Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast by Region
  1.7.1 Global Short-Acting Nicotine Replacement Therapy Products Market Size by Region: 2021 VS 2025 VS 2032
  1.7.2 Global Short-Acting Nicotine Replacement Therapy Products Market Size by Region, (2021-2032)
  1.7.3 North America Short-Acting Nicotine Replacement Therapy Products Market Size and Prospect (2021-2032)
  1.7.4 Europe Short-Acting Nicotine Replacement Therapy Products Market Size and Prospect (2021-2032)
  1.7.5 Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Market Size and Prospect (2021-2032)
  1.7.6 South America Short-Acting Nicotine Replacement Therapy Products Market Size and Prospect (2021-2032)
  1.7.7 Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 Kenvue
  2.1.1 Kenvue Details
  2.1.2 Kenvue Major Business
  2.1.3 Kenvue Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.1.4 Kenvue Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Kenvue Recent Developments and Future Plans
2.2 Perrigo
  2.2.1 Perrigo Details
  2.2.2 Perrigo Major Business
  2.2.3 Perrigo Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.2.4 Perrigo Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Perrigo Recent Developments and Future Plans
2.3 Dr. Reddy's Laboratories
  2.3.1 Dr. Reddy's Laboratories Details
  2.3.2 Dr. Reddy's Laboratories Major Business
  2.3.3 Dr. Reddy's Laboratories Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.3.4 Dr. Reddy's Laboratories Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Dr. Reddy's Laboratories Recent Developments and Future Plans
2.4 Haleon
  2.4.1 Haleon Details
  2.4.2 Haleon Major Business
  2.4.3 Haleon Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.4.4 Haleon Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Haleon Recent Developments and Future Plans
2.5 Philip Morris International
  2.5.1 Philip Morris International Details
  2.5.2 Philip Morris International Major Business
  2.5.3 Philip Morris International Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.5.4 Philip Morris International Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Philip Morris International Recent Developments and Future Plans
2.6 Cipla
  2.6.1 Cipla Details
  2.6.2 Cipla Major Business
  2.6.3 Cipla Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.6.4 Cipla Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Cipla Recent Developments and Future Plans
2.7 Rusan Pharma
  2.7.1 Rusan Pharma Details
  2.7.2 Rusan Pharma Major Business
  2.7.3 Rusan Pharma Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.7.4 Rusan Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Rusan Pharma Recent Developments and Future Plans
2.8 Glenmark Pharmaceuticals
  2.8.1 Glenmark Pharmaceuticals Details
  2.8.2 Glenmark Pharmaceuticals Major Business
  2.8.3 Glenmark Pharmaceuticals Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.8.4 Glenmark Pharmaceuticals Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 Glenmark Pharmaceuticals Recent Developments and Future Plans
2.9 Piramal Pharma
  2.9.1 Piramal Pharma Details
  2.9.2 Piramal Pharma Major Business
  2.9.3 Piramal Pharma Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.9.4 Piramal Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Piramal Pharma Recent Developments and Future Plans
2.10 Rubicon Consumer Healthcare
  2.10.1 Rubicon Consumer Healthcare Details
  2.10.2 Rubicon Consumer Healthcare Major Business
  2.10.3 Rubicon Consumer Healthcare Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.10.4 Rubicon Consumer Healthcare Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Rubicon Consumer Healthcare Recent Developments and Future Plans
2.11 Alkalon
  2.11.1 Alkalon Details
  2.11.2 Alkalon Major Business
  2.11.3 Alkalon Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.11.4 Alkalon Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 Alkalon Recent Developments and Future Plans
2.12 Sparsha Pharma
  2.12.1 Sparsha Pharma Details
  2.12.2 Sparsha Pharma Major Business
  2.12.3 Sparsha Pharma Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.12.4 Sparsha Pharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 Sparsha Pharma Recent Developments and Future Plans
2.13 TFI India Labs
  2.13.1 TFI India Labs Details
  2.13.2 TFI India Labs Major Business
  2.13.3 TFI India Labs Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.13.4 TFI India Labs Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 TFI India Labs Recent Developments and Future Plans
2.14 Nico Orgo Marketing
  2.14.1 Nico Orgo Marketing Details
  2.14.2 Nico Orgo Marketing Major Business
  2.14.3 Nico Orgo Marketing Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.14.4 Nico Orgo Marketing Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 Nico Orgo Marketing Recent Developments and Future Plans
2.15 Lucy Goods
  2.15.1 Lucy Goods Details
  2.15.2 Lucy Goods Major Business
  2.15.3 Lucy Goods Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.15.4 Lucy Goods Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 Lucy Goods Recent Developments and Future Plans
2.16 Blip
  2.16.1 Blip Details
  2.16.2 Blip Major Business
  2.16.3 Blip Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.16.4 Blip Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.16.5 Blip Recent Developments and Future Plans
2.17 AdhexPharma
  2.17.1 AdhexPharma Details
  2.17.2 AdhexPharma Major Business
  2.17.3 AdhexPharma Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.17.4 AdhexPharma Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.17.5 AdhexPharma Recent Developments and Future Plans
2.18 Jones
  2.18.1 Jones Details
  2.18.2 Jones Major Business
  2.18.3 Jones Short-Acting Nicotine Replacement Therapy Products Product and Solutions
  2.18.4 Jones Short-Acting Nicotine Replacement Therapy Products Revenue, Gross Margin and Market Share (2021-2026)
  2.18.5 Jones Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Short-Acting Nicotine Replacement Therapy Products Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Short-Acting Nicotine Replacement Therapy Products by Company Revenue
  3.2.2 Top 3 Short-Acting Nicotine Replacement Therapy Products Players Market Share in 2025
  3.2.3 Top 6 Short-Acting Nicotine Replacement Therapy Products Players Market Share in 2025
3.3 Short-Acting Nicotine Replacement Therapy Products Market: Overall Company Footprint Analysis
  3.3.1 Short-Acting Nicotine Replacement Therapy Products Market: Region Footprint
  3.3.2 Short-Acting Nicotine Replacement Therapy Products Market: Company Product Type Footprint
  3.3.3 Short-Acting Nicotine Replacement Therapy Products Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Short-Acting Nicotine Replacement Therapy Products Consumption Value and Market Share by Type (2021-2026)
4.2 Global Short-Acting Nicotine Replacement Therapy Products Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Application (2021-2026)
5.2 Global Short-Acting Nicotine Replacement Therapy Products Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2032)
6.2 North America Short-Acting Nicotine Replacement Therapy Products Market Size by Application (2021-2032)
6.3 North America Short-Acting Nicotine Replacement Therapy Products Market Size by Country
  6.3.1 North America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2021-2032)
  6.3.2 United States Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  6.3.3 Canada Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  6.3.4 Mexico Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2032)
7.2 Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2032)
7.3 Europe Short-Acting Nicotine Replacement Therapy Products Market Size by Country
  7.3.1 Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2021-2032)
  7.3.2 Germany Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  7.3.3 France Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  7.3.5 Russia Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  7.3.6 Italy Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Market Size by Region
  8.3.1 Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Region (2021-2032)
  8.3.2 China Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  8.3.3 Japan Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  8.3.4 South Korea Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  8.3.5 India Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  8.3.7 Australia Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2032)
9.2 South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2032)
9.3 South America Short-Acting Nicotine Replacement Therapy Products Market Size by Country
  9.3.1 South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2021-2032)
  9.3.2 Brazil Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  9.3.3 Argentina Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Market Size by Country
  10.3.1 Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2021-2032)
  10.3.2 Turkey Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)
  10.3.4 UAE Short-Acting Nicotine Replacement Therapy Products Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Short-Acting Nicotine Replacement Therapy Products Market Drivers
11.2 Short-Acting Nicotine Replacement Therapy Products Market Restraints
11.3 Short-Acting Nicotine Replacement Therapy Products Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Short-Acting Nicotine Replacement Therapy Products Industry Chain
12.2 Short-Acting Nicotine Replacement Therapy Products Upstream Analysis
12.3 Short-Acting Nicotine Replacement Therapy Products Midstream Analysis
12.4 Short-Acting Nicotine Replacement Therapy Products Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES

Table 1. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Dose, (USD Million), 2021 & 2025 & 2032
Table 3. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Kenvue Company Information, Head Office, and Major Competitors
Table 7. Kenvue Major Business
Table 8. Kenvue Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 9. Kenvue Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Kenvue Recent Developments and Future Plans
Table 11. Perrigo Company Information, Head Office, and Major Competitors
Table 12. Perrigo Major Business
Table 13. Perrigo Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 14. Perrigo Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Perrigo Recent Developments and Future Plans
Table 16. Dr. Reddy's Laboratories Company Information, Head Office, and Major Competitors
Table 17. Dr. Reddy's Laboratories Major Business
Table 18. Dr. Reddy's Laboratories Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 19. Dr. Reddy's Laboratories Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Haleon Company Information, Head Office, and Major Competitors
Table 21. Haleon Major Business
Table 22. Haleon Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 23. Haleon Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Haleon Recent Developments and Future Plans
Table 25. Philip Morris International Company Information, Head Office, and Major Competitors
Table 26. Philip Morris International Major Business
Table 27. Philip Morris International Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 28. Philip Morris International Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Philip Morris International Recent Developments and Future Plans
Table 30. Cipla Company Information, Head Office, and Major Competitors
Table 31. Cipla Major Business
Table 32. Cipla Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 33. Cipla Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Cipla Recent Developments and Future Plans
Table 35. Rusan Pharma Company Information, Head Office, and Major Competitors
Table 36. Rusan Pharma Major Business
Table 37. Rusan Pharma Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 38. Rusan Pharma Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Rusan Pharma Recent Developments and Future Plans
Table 40. Glenmark Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Glenmark Pharmaceuticals Major Business
Table 42. Glenmark Pharmaceuticals Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 43. Glenmark Pharmaceuticals Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Glenmark Pharmaceuticals Recent Developments and Future Plans
Table 45. Piramal Pharma Company Information, Head Office, and Major Competitors
Table 46. Piramal Pharma Major Business
Table 47. Piramal Pharma Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 48. Piramal Pharma Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Piramal Pharma Recent Developments and Future Plans
Table 50. Rubicon Consumer Healthcare Company Information, Head Office, and Major Competitors
Table 51. Rubicon Consumer Healthcare Major Business
Table 52. Rubicon Consumer Healthcare Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 53. Rubicon Consumer Healthcare Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Rubicon Consumer Healthcare Recent Developments and Future Plans
Table 55. Alkalon Company Information, Head Office, and Major Competitors
Table 56. Alkalon Major Business
Table 57. Alkalon Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 58. Alkalon Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Alkalon Recent Developments and Future Plans
Table 60. Sparsha Pharma Company Information, Head Office, and Major Competitors
Table 61. Sparsha Pharma Major Business
Table 62. Sparsha Pharma Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 63. Sparsha Pharma Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Sparsha Pharma Recent Developments and Future Plans
Table 65. TFI India Labs Company Information, Head Office, and Major Competitors
Table 66. TFI India Labs Major Business
Table 67. TFI India Labs Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 68. TFI India Labs Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. TFI India Labs Recent Developments and Future Plans
Table 70. Nico Orgo Marketing Company Information, Head Office, and Major Competitors
Table 71. Nico Orgo Marketing Major Business
Table 72. Nico Orgo Marketing Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 73. Nico Orgo Marketing Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Nico Orgo Marketing Recent Developments and Future Plans
Table 75. Lucy Goods Company Information, Head Office, and Major Competitors
Table 76. Lucy Goods Major Business
Table 77. Lucy Goods Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 78. Lucy Goods Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Lucy Goods Recent Developments and Future Plans
Table 80. Blip Company Information, Head Office, and Major Competitors
Table 81. Blip Major Business
Table 82. Blip Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 83. Blip Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Blip Recent Developments and Future Plans
Table 85. AdhexPharma Company Information, Head Office, and Major Competitors
Table 86. AdhexPharma Major Business
Table 87. AdhexPharma Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 88. AdhexPharma Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. AdhexPharma Recent Developments and Future Plans
Table 90. Jones Company Information, Head Office, and Major Competitors
Table 91. Jones Major Business
Table 92. Jones Short-Acting Nicotine Replacement Therapy Products Product and Solutions
Table 93. Jones Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Jones Recent Developments and Future Plans
Table 95. Global Short-Acting Nicotine Replacement Therapy Products Revenue (USD Million) by Players (2021-2026)
Table 96. Global Short-Acting Nicotine Replacement Therapy Products Revenue Share by Players (2021-2026)
Table 97. Breakdown of Short-Acting Nicotine Replacement Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Short-Acting Nicotine Replacement Therapy Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 99. Head Office of Key Short-Acting Nicotine Replacement Therapy Products Players
Table 100. Short-Acting Nicotine Replacement Therapy Products Market: Company Product Type Footprint
Table 101. Short-Acting Nicotine Replacement Therapy Products Market: Company Product Application Footprint
Table 102. Short-Acting Nicotine Replacement Therapy Products New Market Entrants and Barriers to Market Entry
Table 103. Short-Acting Nicotine Replacement Therapy Products Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value (USD Million) by Type (2021-2026)
Table 105. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Share by Type (2021-2026)
Table 106. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Forecast by Type (2027-2032)
Table 107. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2026)
Table 108. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Forecast by Application (2027-2032)
Table 109. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2026) & (USD Million)
Table 110. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2027-2032) & (USD Million)
Table 111. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2026) & (USD Million)
Table 112. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2027-2032) & (USD Million)
Table 113. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2021-2026) & (USD Million)
Table 114. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2027-2032) & (USD Million)
Table 115. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2026) & (USD Million)
Table 116. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2027-2032) & (USD Million)
Table 117. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2026) & (USD Million)
Table 124. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2027-2032) & (USD Million)
Table 125. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Region (2021-2026) & (USD Million)
Table 126. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value by Region (2027-2032) & (USD Million)
Table 127. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2026) & (USD Million)
Table 128. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2027-2032) & (USD Million)
Table 129. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2026) & (USD Million)
Table 130. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2027-2032) & (USD Million)
Table 131. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2021-2026) & (USD Million)
Table 132. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2021-2026) & (USD Million)
Table 134. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type (2027-2032) & (USD Million)
Table 135. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2021-2026) & (USD Million)
Table 136. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application (2027-2032) & (USD Million)
Table 137. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2021-2026) & (USD Million)
Table 138. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Global Key Players of Short-Acting Nicotine Replacement Therapy Products Upstream (Raw Materials)
Table 140. Global Short-Acting Nicotine Replacement Therapy Products Typical Customers

LIST OF FIGURES

Figure 1. Short-Acting Nicotine Replacement Therapy Products Picture
Figure 2. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Type in 2025
Figure 4. Nicotine Gum
Figure 5. Nicotine Lozenges
Figure 6. Nicotine Mouth Spray
Figure 7. Nicotine Nasal Spray
Figure 8. Others
Figure 9. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Dose, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Dose in 2025
Figure 11. Low Dose
Figure 12. Medium Dose
Figure 13. High Dose
Figure 14. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 15. Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Application in 2025
Figure 16. Online Sales Picture
Figure 17. Offline Sales Picture
Figure 18. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global Market Short-Acting Nicotine Replacement Therapy Products Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 21. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Region (2021-2032)
Figure 22. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Region in 2025
Figure 23. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 26. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 28. Company Three Recent Developments and Future Plans
Figure 29. Global Short-Acting Nicotine Replacement Therapy Products Revenue Share by Players in 2025
Figure 30. Short-Acting Nicotine Replacement Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 31. Market Share of Short-Acting Nicotine Replacement Therapy Products by Player Revenue in 2025
Figure 32. Top 3 Short-Acting Nicotine Replacement Therapy Products Players Market Share in 2025
Figure 33. Top 6 Short-Acting Nicotine Replacement Therapy Products Players Market Share in 2025
Figure 34. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Share by Type (2021-2026)
Figure 35. Global Short-Acting Nicotine Replacement Therapy Products Market Share Forecast by Type (2027-2032)
Figure 36. Global Short-Acting Nicotine Replacement Therapy Products Consumption Value Share by Application (2021-2026)
Figure 37. Global Short-Acting Nicotine Replacement Therapy Products Market Share Forecast by Application (2027-2032)
Figure 38. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Type (2021-2032)
Figure 39. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Application (2021-2032)
Figure 40. North America Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Country (2021-2032)
Figure 41. United States Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 42. Canada Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 43. Mexico Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 44. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Type (2021-2032)
Figure 45. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Application (2021-2032)
Figure 46. Europe Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Country (2021-2032)
Figure 47. Germany Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 48. France Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 49. United Kingdom Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 50. Russia Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 51. Italy Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 52. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Type (2021-2032)
Figure 53. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Application (2021-2032)
Figure 54. Asia-Pacific Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Region (2021-2032)
Figure 55. China Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 56. Japan Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 57. South Korea Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 58. India Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 59. Southeast Asia Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 60. Australia Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 61. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Type (2021-2032)
Figure 62. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Application (2021-2032)
Figure 63. South America Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Type (2021-2032)
Figure 67. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Application (2021-2032)
Figure 68. Middle East & Africa Short-Acting Nicotine Replacement Therapy Products Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 70. Saudi Arabia Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 71. UAE Short-Acting Nicotine Replacement Therapy Products Consumption Value (2021-2032) & (USD Million)
Figure 72. Short-Acting Nicotine Replacement Therapy Products Market Drivers
Figure 73. Short-Acting Nicotine Replacement Therapy Products Market Restraints
Figure 74. Short-Acting Nicotine Replacement Therapy Products Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Short-Acting Nicotine Replacement Therapy Products Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source